NewsRoom Articles - Page 260 of 606

FridayJul 09, 2021 4:20 am

420 with CNW — Congress Gears Up to Consider Spending Bills Touching on Marijuana, CBD and Hemp

Just a day after the House Appropriations Committee released a report urging federal agencies to reconsider firing employees for past cannabis use, several cannabis and hemp-related spending bills have advanced in Congress. As the 2022 midterms approach, Democrats have limited time to advance cannabis legislation before the Republican Party challenges their tenuous hold on Congress. If these bills are successful, they could have far-reaching effects on the cannabis and hemp industries. For starters, the House Appropriations Committee approved a bill with an attached report acknowledging clarification from the U.S. Department of Veterans Affairs (“VA”) that veterans who work in the…

ThursdayJul 08, 2021 4:20 pm

420 with CNW — Study Finds That Marijuana Possesses Strain-Specific Effect on Driving Performance

A recent study has found that drivers who consume marijuana may not perform or feel impaired. The study found that, instead, drivers who used marijuana would sometimes experience a positive effect on their driving. This comes at a time when policy makers are working to decide whether driving while under the influence of marijuana warrants similar penalties to driving while under the influence of alcohol in various states across the country. Under the law, impairment is defined as a state of diminished or weakened function. In many states, the legal limit for blood–alcohol content is 0.08. It is known that…

ThursdayJul 08, 2021 12:04 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Positive Results From its Recent Animal Study on the Effectiveness of its DehydraTECH Drug Delivery Technology

Lexaria Bioscience Corp. announced positive results from its VIRAL-A20-2 study This study showed strong gains in delivery of the DehydraTECH-enabled remdesivir and ebastine among animals The success of this study shows the potential and commercial viability of Lexaria’s DehydraTECH In June 2021, Lexaria Bioscience (NASDAQ: LEXX) announced positive results from its VIRAL-A20-2 study that evaluated the effectiveness of DehydraTECH-enabled remdesivir and ebastine among animals. The results were strongly positive and demonstrated greater effectiveness than in Lexaria’s first antiviral drug study reported in December 2000. The research was a tolerability and pharmacokinetic (“PK”) study involving four groups of 10 animals each.…

ThursdayJul 08, 2021 4:20 am

420 with CNW — Five Science-Based Benefits of Cannabidiol

Cannabis and cannabis extracts are becoming more popular as more states across the country legalize the plant for recreational and/or medical use. CBD, or cannabidiol, is a chemical compound that is extracted from the cannabis sativa plant. The compound can be consumed through edible consumption or smoke inhalation, in addition to being applied topically. It interacts with neuro-receptors in an individual’s endocannabinoid system, which send signals between the body’s cells to help regulate the immune system, homeostasis, mood and movement. Cannabidiol is usually extracted in oil form and has recently become popular because of its calming effects. Below are a…

WednesdayJul 07, 2021 4:20 pm

420 with CNW — Supreme Court Justice Slams Federal Cannabis Policy as Unstable, Contradictory

Until a decade or so ago, America's policy on cannabis had been outright prohibition. Marijuana was illegal to grow, produce or sell in nearly every state, and individuals who participated in any of these activities were subject to intense policing and harsh sentencing. Now more than 30 states allow some form of cannabis, and the industry has employed hundreds of thousands and provided states with millions of dollars in tax revenue. However, federal law still classifies marijuana as a Schedule I controlled substance, similar to hard drugs such as cocaine and heroin. Additionally, most states have different cannabis regulations, and…

WednesdayJul 07, 2021 12:03 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Positioning Itself to Compete in US Functional Beverage Market

“Forbes” article notes that $20 million Naturo Group acquisition creates ideal situation for BevCanna expansion BevCanna boasts one of most unique, diverse portfolios of beverage and natural health products within both cannabis, plant-based industries Combination of two Canadian beverage industry leaders unlocks significant potential for growth As Canadian cannabis company BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) expands its infused functional beverage business into the United States, its deliberate, transformative strategy has garnered a mention in a recent “Forbes” article. Titled “BevCanna Expands in the U.S. Infused Functional Beverage Market Upon Acquiring Naturo Group,” the article noted that the…

WednesdayJul 07, 2021 4:20 am

420 with CNW — Fibromyalgia Patients Ditching Opioids for CBD to Manage Pain

Fibromyalgia is a disorder that presents as musculoskeletal pain accompanied by mood, memory, sleep and fatigue issues. This disorder has no cure, and while there are drugs that can help manage its symptoms, most don’t do the job perfectly. However, a new study conducted by researchers from the School of Medicine at the University of Michigan has found that patients with fibromyalgia may benefit from the use of products that contain CBD to manage pain. CBD, or cannabidiol, is a cannabinoid that is extracted from the marijuana plant that doesn’t induce the intoxicating effects of THC. This cannabinoid has been…

TuesdayJul 06, 2021 4:20 pm

420 with CNW — Congressional Committee Authors Report Urging Feds to Rethink Firing Employees Who Use Marijuana

Although federal law still classifies cannabis as a Schedule I controlled substance, more than 30 states have legalized it for either medical or recreational use. This classification has been a constant thorn in the industry's side, preventing businesses in the cannabis space from accessing crucial banking and financial services. Cannabis consumers have also been caught in the middle, with many of them being penalized by the federal government for actions that are considered legal in their home states. As such, a powerful Congressional committee has released a report urging federal agencies to reconsider firing employees for using state-legal marijuana. Alongside…

TuesdayJul 06, 2021 9:30 am

Hero Technologies Inc. (HENC) Is Leading Cannabis Player as Trend Moves Toward Greenhouse Cultivation

Greenhouse production continues to be the no. 1 tool for reducing initial operational costs. The report analyzed five years of data to identify key trends in the cannabis cultivation market. The average cost to grow a pound of dried flower was $396 for warehouse cultivation sites, only $233 for greenhouse sites. According to a recent five-year study of the cannabis industry, greenhouse production is a leading choice for cannabis cultivation companies (https://cnw.fm/1JlbG). The report, published by “Cannabis Business Times,” reaffirms the business strategy of Hero Technologies (OTC: HENC), a cannabis company that is focused on growing into a multistate, vertically integrated entity…

TuesdayJul 06, 2021 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) Announces Milestone in Antiviral Delivery Platform Testing

Drug delivery platform developer Lexaria Bioscience has been testing its patented technology in conjunction with antivirals Remdesivir and Ebastine during the past year to determine the potential for enhancing their effectiveness against the COVID-19 virus Early-stage testing has determined Lexaria’s technology — DehydraTECH — did not inhibit Remdesivir and Ebastine in their use against the virus DehydraTECH is a technology that helps drugs gain better bioavailability through effective introduction into patients’ bloodstreams The DehydraTECH platform has also shown great potential in enhancing hypertension medication and additional trials are ongoing Pharmaceutical use and bioavailability innovator Lexaria Bioscience (NASDAQ: LEXX) (CSE: LXX)…

News and publishing service for cannabis related companies

Contact us: 512.354.7000